Paper41272152
Altered systemic bioenergetic reserve in chronic kidney disease predisposes hearts to worse functional outcomes.
Young M and 15 others. Sci Rep, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Altered systemic bioenergetic reserve in chronic kidney disease predisposes hearts to worse functional outcomes. Papers, record 41272152. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41272152
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Altered systemic bioenergetic reserve in chronic kidney disease predisposes hearts to worse functional outcomes.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Renal Insufficiency, Chronic | Major topic |
| Energy Metabolism | Major topic |
| Myocardium | Major topic |
| Heart | Major topic |
| Animals | |
| Rats | |
| Male | |
| Humans | |
| Muscle, Skeletal | |
| Disease Models, Animal | |
| Kidney | |
| Magnetic Resonance Spectroscopy | |
| Metabolomics | |
| Liver |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 21-0299 | APVV | PubMed | ||
| 221604/Z/20/Z | Wellcome Trust | United Kingdom | PubMed | |
| 2/0004/23 | VEGA | PubMed | ||
| RE/24/130035 | British Heart Foundation | United Kingdom | PubMed | |
| NNF21OC0068683 | Novo Nordisk Fonden | PubMed | ||
| FS/4YPhD/P/20/34016 | British Heart Foundation | United Kingdom | PubMed | |
| WT/203148/Z/16/Z | EPSRC | PubMed | ||
| G-002145 | Barts Charity | PubMed | ||
| Wellcome Trust | United Kingdom | PubMed |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35529086 | Epidemiology of chronic kidney disease: an update 2022. | Kidney Int Suppl (2011) | 2022 | https://conductscience.org/library/papers/35529086 | PubMed |
| 2 | 37053280 | Cardiac Metabolism in Heart Failure and Implications for Uremic Cardiomyopathy. | Circ Res | 2023 | https://conductscience.org/library/papers/37053280 | PubMed |
| 3 | 35064159 | Impact of reduced uterine perfusion pressure model of preeclampsia on metabolism of placenta, maternal and fetal hearts. | Sci Rep | 2022 | https://conductscience.org/library/papers/35064159 | PubMed |
| 4 | 28608457 | Potential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction. | J Cachexia Sarcopenia Muscle | 2017 | https://conductscience.org/library/papers/28608457 | PubMed |
| 5 | 25878055 | AST-120 ameliorates lowered exercise capacity and mitochondrial biogenesis in the skeletal muscle from mice with chronic kidney disease via reducing oxidative stress. | Nephrol Dial Transplant | 2015 | https://conductscience.org/library/papers/25878055 | PubMed |
| 6 | 28427790 | Exercise and CKD: Skeletal Muscle Dysfunction and Practical Application of Exercise to Prevent and Treat Physical Impairments in CKD. | Am J Kidney Dis | 2017 | https://conductscience.org/library/papers/28427790 | PubMed |
| 7 | 35637381 | Cardiac metabolic remodelling in chronic kidney disease. | Nat Rev Nephrol | 2022 | https://conductscience.org/library/papers/35637381 | PubMed |
| 8 | 32591420 | Role of Skeletal Muscle Mitochondrial Dysfunction in CKD. | Clin J Am Soc Nephrol | 2020 | https://conductscience.org/library/papers/32591420 | PubMed |
| 9 | 19177156 | Insulin resistance and altered glucose transporter 4 expression in experimental uremia. | Kidney Int | 2009 | https://conductscience.org/library/papers/19177156 | PubMed |
| 10 | 33290279 | Impaired muscle mitochondrial energetics is associated with uremic metabolite accumulation in chronic kidney disease. | JCI Insight | 2020 | https://conductscience.org/library/papers/33290279 | PubMed |
| 11 | 25587120 | Mitochondrial dysfunction in uremic cardiomyopathy. | Am J Physiol Renal Physiol | 2015 | https://conductscience.org/library/papers/25587120 | PubMed |
| 12 | 27307758 | Myocardial bioenergetic abnormalities in experimental uremia. | Int J Nephrol Renovasc Dis | 2016 | https://conductscience.org/library/papers/27307758 | PubMed |
| 13 | 24569863 | Elevated hepatic 11β-hydroxysteroid dehydrogenase type 1 induces insulin resistance in uremia. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/24569863 | PubMed |
| 14 | 34054588 | Uremic Toxins: An Alarming Danger Concerning the Cardiovascular System. | Front Physiol | 2021 | https://conductscience.org/library/papers/34054588 | PubMed |
| 15 | 35715563 | Chronic kidney disease is a key predictive factor for potential myocardial ischaemia and poor prognosis in asymptomatic patients with diabetes mellitus. | Sci Rep | 2022 | https://conductscience.org/library/papers/35715563 | PubMed |
| 16 | 23274953 | p-Cresyl sulfate promotes insulin resistance associated with CKD. | J Am Soc Nephrol | 2013 | https://conductscience.org/library/papers/23274953 | PubMed |
| 17 | 24729784 | Chronic kidney disease and nonalcoholic Fatty liver disease-is there a link? | Gastroenterol Res Pract | 2014 | https://conductscience.org/library/papers/24729784 | PubMed |
| 18 | 8479125 | 31P NMR spectroscopy investigation of muscle metabolism in hemodialysis patients. | Kidney Int | 1993 | https://conductscience.org/library/papers/8479125 | PubMed |
| 19 | 19633100 | Cellular basis of uraemic cardiomyopathy: a role for erythropoietin? | Eur J Heart Fail | 2009 | https://conductscience.org/library/papers/19633100 | PubMed |
| 20 | 36791683 | AST-120 to Target Protein-Bound Uremic Toxins Improves Cardiac Output and Kidney Oxygenation in Experimental Chronic Kidney Disease. | Kidney Blood Press Res | 2023 | https://conductscience.org/library/papers/36791683 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42578286 | Dual inhibition of SGLT 1 and 2 by sotagliflozin alleviates intracellular sodium overload and improves cardiometabolic remodelling in uraemic cardiomyopathy. | Cardiovasc Res | 2026 | https://conductscience.org/library/papers/42578286 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41272152
GET https://conductscience.org/api/papers/v1/41272152/references?page=2